Zimmer Biomet Holdings, Inc. (ZBH) Q1 2026 Earnings Call Transcript
Zimmer Biomet Holdings reported financial results for the first quarter of 2026 during its earnings call, highlighting performance across its orthopedic product lines and operational updates. Leadership discussed revenue trends, cost management, and strategic initiatives aimed at driving growth. The company maintained a cautious outlook amid ongoing macroeconomic and healthcare utilization challenges. Executives also addressed investor questions on innovation, margins, and market competition.
- ▪Zimmer Biomet's Q1 2026 earnings call took place on April 28, 2026, led by CEO Ivan Tornos, CFO Suketu Upadhyay, and SVP David DeMartino.
- ▪The company reported quarterly financial results with commentary on revenue performance, particularly in knee, hip, and spine product segments.
- ▪Management emphasized progress in supply chain efficiency and cost optimization initiatives.
- ▪Executives noted persistent softness in elective procedure volumes as a headwind to growth.
- ▪Zimmer Biomet reaffirmed its full-year 2026 financial guidance despite macroeconomic pressures.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4895092-zimmer-biomet-holdings-inc-zbh-q1-2026-earnings-call-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
